CNS Pharmaceuticals Inc (CNSP)
0.109
0.00 (0.00%)
USD |
NASDAQ |
Dec 24, 16:00
CNS Pharmaceuticals Free Cash Flow: -14.18M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ligand Pharmaceuticals Inc | 6.968M |
| Cellectar Biosciences Inc | -46.57M |
| Revance Therapeutics Inc | -194.91M |
| Zymeworks Inc | -59.09M |
| NovaBay Pharmaceuticals Inc | -4.812M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -6.80M |
| Cash from Financing (Quarterly) | 12.28M |
| Free Cash Flow Per Share (Quarterly) | -0.3066 |
| Free Cash Flow Yield | -2.28K% |